Protara Therapeutics (TARA) Other financing activities (2014 - 2024)

Protara Therapeutics' Other financing activities history runs 6 years deep, the most recent figure standing at $385000.0 for Q1 2024.

• In Q1 2024, Other financing activities fell 69.47% year-over-year to $385000.0; the TTM figure through Mar 2024 stood at $4.0 million (down 21.58% YoY), while the FY2023 annual figure was $4.9 million, down 9.81% from the prior year.
• Other financing activities was $385000.0 for Q1 2024 at Protara Therapeutics, down from $1.2 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $7.4 million in Q4 2020 to a low of $368000.0 in Q1 2020.
• Historically, Other financing activities has averaged $1.5 million across 5 years, with a median of $1.3 million in 2023.
• Biggest YoY gain for Other financing activities was 290.49% in 2021; the steepest drop was 81.62% in 2021.
• A 5-year view of Other financing activities shows it stood at $7.4 million in 2020, then sank by 81.62% to $1.4 million in 2021, then declined by 15.46% to $1.1 million in 2022, then advanced by 0.96% to $1.2 million in 2023, then sank by 66.78% to $385000.0 in 2024.
• The last three Other financing activities figures came in at $385000.0 (Q1 2024), $1.2 million (Q4 2023), and $1.2 million (Q3 2023), per Business Quant data.